Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 191

1.

Progressive Loss Of Myogenic Differentiation In Leiomyosarcoma Has Prognostic Value.

Demicco EG, Boland GM, Brewer Savannah KJ, Lusby K, Young ED, Ingram D, Watson KL, Bailey M, Guo X, Hornick JL, van de Rijn M, Wang WL, Torres KE, Lev D, Lazar AJ.

Histopathology. 2014 May 30. doi: 10.1111/his.12466. [Epub ahead of print]

PMID:
24889065
[PubMed - as supplied by publisher]
2.

Dystrophin is a tumor suppressor in human cancers with myogenic programs.

Wang Y, Marino-Enriquez A, Bennett RR, Zhu M, Shen Y, Eilers G, Lee JC, Henze J, Fletcher BS, Gu Z, Fox EA, Antonescu CR, Fletcher CD, Guo X, Raut CP, Demetri GD, van de Rijn M, Ordog T, Kunkel LM, Fletcher JA.

Nat Genet. 2014 Jun;46(6):601-6. doi: 10.1038/ng.2974. Epub 2014 May 4.

PMID:
24793134
[PubMed - indexed for MEDLINE]
3.

Stromal responses among carcinomas--response.

West RB, van de Rijn M, Chen JL.

Clin Cancer Res. 2014 Mar 1;20(5):1397. doi: 10.1158/1078-0432.CCR-13-3238. No abstract available.

PMID:
24590889
[PubMed - in process]
4.

Next generation sequencing-based expression profiling identifies signatures from benign stromal proliferations that define stromal components of breast cancer.

Guo X, Zhu SX, Brunner AL, van de Rijn M, West RB.

Breast Cancer Res. 2013 Dec 17;15(6):R117. doi: 10.1186/bcr3586.

PMID:
24342436
[PubMed - in process]
Free PMC Article
5.

Stromal signatures in endometrioid endometrial carcinomas.

Espinosa I, Catasus L, D' Angelo E, Mozos A, Pedrola N, Bértolo C, Ferrer I, Zannoni GF, West RB, van de Rijn M, Matias-Guiu X, Prat J.

Mod Pathol. 2014 Apr;27(4):631-9. doi: 10.1038/modpathol.2013.131. Epub 2013 Nov 22.

PMID:
24263966
[PubMed - in process]
6.

Molecular pathological analysis of sarcomas using paraffin-embedded tissue: current limitations and future possibilities.

van de Rijn M, Guo X, Sweeney RT, Beck AH, West RB.

Histopathology. 2014 Jan;64(1):163-70. doi: 10.1111/his.12290. Epub 2013 Nov 25. Review.

PMID:
24107169
[PubMed - indexed for MEDLINE]
7.

Use of a KIT-specific monoclonal antibody to bypass imatinib resistance in gastrointestinal stromal tumors.

Edris B, Willingham S, Weiskopf K, Volkmer AK, Volkmer JP, Mühlenberg T, Weissman IL, van de Rijn M.

Oncoimmunology. 2013 Jun 1;2(6):e24452. Epub 2013 May 14.

PMID:
23894705
[PubMed]
Free PMC Article
8.

Stromal responses among common carcinomas correlated with clinicopathologic features.

Chen JL, Espinosa I, Lin AY, Liao OY, van de Rijn M, West RB.

Clin Cancer Res. 2013 Sep 15;19(18):5127-35. doi: 10.1158/1078-0432.CCR-12-3127. Epub 2013 Jun 26.

PMID:
23804424
[PubMed - in process]
9.

Engineered SIRPα variants as immunotherapeutic adjuvants to anticancer antibodies.

Weiskopf K, Ring AM, Ho CC, Volkmer JP, Levin AM, Volkmer AK, Ozkan E, Fernhoff NB, van de Rijn M, Weissman IL, Garcia KC.

Science. 2013 Jul 5;341(6141):88-91. doi: 10.1126/science.1238856. Epub 2013 May 30.

PMID:
23722425
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Post-transcriptional dysregulation by miRNAs is implicated in the pathogenesis of gastrointestinal stromal tumor [GIST].

Kelly L, Bryan K, Kim SY, Janeway KA, Killian JK, Schildhaus HU, Miettinen M, Helman L, Meltzer PS, van de Rijn M, Debiec-Rychter M, O'Sullivan M; NIH Pediatric and Wild-Type GIST Clinic.

PLoS One. 2013 May 24;8(5):e64102. doi: 10.1371/journal.pone.0064102. Print 2013.

PMID:
23717541
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer types.

Giacomini CP, Sun S, Varma S, Shain AH, Giacomini MM, Balagtas J, Sweeney RT, Lai E, Del Vecchio CA, Forster AD, Clarke N, Montgomery KD, Zhu S, Wong AJ, van de Rijn M, West RB, Pollack JR.

PLoS Genet. 2013 Apr;9(4):e1003464. doi: 10.1371/journal.pgen.1003464. Epub 2013 Apr 25.

PMID:
23637631
[PubMed - in process]
Free PMC Article
12.

Desktop transcriptome sequencing from archival tissue to identify clinically relevant translocations.

Sweeney RT, Zhang B, Zhu SX, Varma S, Smith KS, Montgomery SB, van de Rijn M, Zehnder J, West RB.

Am J Surg Pathol. 2013 Jun;37(6):796-803. doi: 10.1097/PAS.0b013e31827ad9b2.

PMID:
23598961
[PubMed - indexed for MEDLINE]
13.

Modeling clear cell sarcomagenesis in the mouse: cell of origin differentiation state impacts tumor characteristics.

Straessler KM, Jones KB, Hu H, Jin H, van de Rijn M, Capecchi MR.

Cancer Cell. 2013 Feb 11;23(2):215-27. doi: 10.1016/j.ccr.2012.12.019.

PMID:
23410975
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Anti-KIT monoclonal antibody inhibits imatinib-resistant gastrointestinal stromal tumor growth.

Edris B, Willingham SB, Weiskopf K, Volkmer AK, Volkmer JP, Mühlenberg T, Montgomery KD, Contreras-Trujillo H, Czechowicz A, Fletcher JA, West RB, Weissman IL, van de Rijn M.

Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3501-6. doi: 10.1073/pnas.1222893110. Epub 2013 Feb 4.

PMID:
23382202
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Flipping the script on macrophages in leiomyosarcoma.

Edris B, Weiskopf K, Weissman IL, van de Rijn M.

Oncoimmunology. 2012 Oct 1;1(7):1202-1204.

PMID:
23170280
[PubMed]
Free PMC Article
16.

CDX2 is an amplified lineage-survival oncogene in colorectal cancer.

Salari K, Spulak ME, Cuff J, Forster AD, Giacomini CP, Huang S, Ko ME, Lin AY, van de Rijn M, Pollack JR.

Proc Natl Acad Sci U S A. 2012 Nov 13;109(46):E3196-205. doi: 10.1073/pnas.1206004109. Epub 2012 Oct 29.

PMID:
23112155
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement.

Lee CH, Ali RH, Rouzbahman M, Marino-Enriquez A, Zhu M, Guo X, Brunner AL, Chiang S, Leung S, Nelnyk N, Huntsman DG, Blake Gilks C, Nielsen TO, Dal Cin P, van de Rijn M, Oliva E, Fletcher JA, Nucci MR.

Am J Surg Pathol. 2012 Oct;36(10):1562-70.

PMID:
22982899
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Transcriptional profiling of long non-coding RNAs and novel transcribed regions across a diverse panel of archived human cancers.

Brunner AL, Beck AH, Edris B, Sweeney RT, Zhu SX, Li R, Montgomery K, Varma S, Gilks T, Guo X, Foley JW, Witten DM, Giacomini CP, Flynn RA, Pollack JR, Tibshirani R, Chang HY, van de Rijn M, West RB.

Genome Biol. 2012 Aug 28;13(8):R75. doi: 10.1186/gb-2012-13-8-r75.

PMID:
22929540
[PubMed - in process]
Free PMC Article
19.

Comparative gene expression profiling of benign and malignant lesions reveals candidate therapeutic compounds for leiomyosarcoma.

Edris B, Fletcher JA, West RB, van de Rijn M, Beck AH.

Sarcoma. 2012;2012:805614. doi: 10.1155/2012/805614. Epub 2012 Aug 5.

PMID:
22919280
[PubMed]
Free PMC Article
20.

Sox10 and S100 in the diagnosis of soft-tissue neoplasms.

Karamchandani JR, Nielsen TO, van de Rijn M, West RB.

Appl Immunohistochem Mol Morphol. 2012 Oct;20(5):445-50. doi: 10.1097/PAI.0b013e318244ff4b.

PMID:
22495377
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk